Save
Email
Print
Share
RSSBrowse News Stories
141 to 150 of 1,021 stories
view headlines only
-
Marked for Destruction: Newly Developed Compound Triggers Cancer Cell Death
May 24, 2012 — Scientists have developed a compound that enhance cell death in cancer ... > full story -
Anti-Psychotic Drug Pushes Cancer Stem Cells Over the Edge
May 24, 2012 — An anti-psychotic drug used to treat schizophrenia appears to get rid of cancer stem cells by helping them differentiate into less threatening cell types. The discovery comes after researchers ... > full storyMore: -
Heparin-Like Compounds Inhibit Breast Cancer Metastasis to Bone
May 21, 2012 — Researchers have discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer ... > full story -
Marker to Identify, Attack Breast Cancer Stem Cells Discovered
May 16, 2012 — Cell surface protein GD2 blows potent tumor-generating cells’ cover. The first single marker of breast cancer stem cells also is targetable by a drug in preclinical ... > full story -
'Fertilizing' Bone Marrow Helps Answer Why Some Cancers Spread to Bones
May 15, 2012 — Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more ... > full story -
A microRNA Prognostic Marker Identified in Acute Leukemia
May 14, 2012 — A study has identified microRNA-3151 as a new independent prognostic marker in patients with acute myeloid leukemia that has normal-looking chromosomes. High levels of this microRNA in cancer cells ... > full story -
New Maintenance Therapy for Multiple Myeloma Looks Promising, Study Suggests
May 11, 2012 — Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. ... > full story -
Leukemia
Chronic Illness
Diseases and Conditions
Multiple Sclerosis Research
Wounds and Healing
Today's Healthcare
Lenalidomide Shows Significant Benefit for Myeloma Patients, Phase III Study Suggests
May 9, 2012 — Medical researchers report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell ... > full story -
Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects of Chemotherapy, Study Suggests
May 9, 2012 — For the first time, scientists have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. ... > full story -
Leukemia Cells Have a Remembrance of Things Past
April 24, 2012 — Although people generally talk about “cancer”, it is clear that the disease occurs in a bewildering variety of forms. Even single groups of cancers, such as those of the white blood ... > full story
Search ScienceDaily
Number of stories in archives: 138,557
more 
